- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01344590
Ethanol Lock for Prevention of Central Line-Associated Blood Stream Infections
Vascular access via central venous lines (CVL) is essential to the care of many patients in the intensive care setting. While the value of these lines for the management of critically ill patients is generally accepted, the potential for line-associated blood stream infection is a known complication of the use of this intervention.
Ethanol is an effective antimicrobial agent with activity against a broad spectrum of human pathogens.
The purpose of this study is to evaluate the effectiveness of daily treatment of the catheter lumen with ethanol to prevent central line associated blood stream infections (CLABSI). The hypothesis is that this treatment will reduce the incidence of CLABSI compared to maintenance of the lines with normal saline alone.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Blood stream infections are an important complication of the use of central venous lines (CVLs) and result in increased morbidity, mortality, and cost. Blood stream infections related to CVLs may be the result of migration of skin organisms along the catheter tract or introduction of organisms into the lumen of the catheter. The extraluminal route of infection appears to be most common early after catheter insertion while the frequency of infection acquired by the intraluminal route appears to increase the longer the catheter is in place. Meticulous attention to best practices for insertion and the subsequent care of the insertion site reduces infection by the extraluminal route. Adherence to good technique for entering the line may similarly reduce infection by the intraluminal route.
Ethanol is an effective antimicrobial agent with activity against a broad spectrum of human pathogens; including the bacteria and fungi which most commonly infect CVLs. The mechanism of the antimicrobial activity of ethanol is attributed to the ability to denature proteins and induced resistance to the effect of ethanol has not been reported. These features suggest that ethanol-lock is a promising approach to the prevention of acquisition of central line associated blood stream infections by the intraluminal route.
Studietyp
Inskrivning (Förväntat)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Ron Turner, MD
- Telefonnummer: 434-243-9864
- E-post: rbt2n@virginia.edu
Studieorter
-
-
Virginia
-
Charlottesville, Virginia, Förenta staterna, 22903
- Rekrytering
- University of Virginia
-
Kontakt:
- Donna Weakley-Marion
- Telefonnummer: 434-924-2169
- E-post: dw4c@virginia.edu
-
Huvudutredare:
- Ron Turner, MD
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Barn
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Although this study is done in the patient-care setting, patients are not the subject of the study. The outcome of interest involves the development of CLABSI in patients but the intervention is directed at the patient's central lines rather than the patient. There are no inclusion or exclusion criteria; the determination of the line care regimen will be determined by the bed assignment rather than any characteristics of the patient occupying the bed.
All central line will be included in this study. Use of ethanol will be suspended whenever the usage of the line precludes instillation of ethanol with a dwell time of al least one hour.
Studieplan
Hur är studien utformad?
Designdetaljer
- Tilldelning: Randomiserad
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: saline lock maintenance
Standard saline lock maintenance
|
Standard saline procedure will be utilized.
|
Experimentell: ethanol maintenance
Instillation of 70% pharmaceutical grade ethanol solution into the central line in a volume calculated to fill the catheter lumen and hub.
|
70% pharmaceutical grade ethanol will be instilled in the line in a volume calculated to fill the lumen and the hub.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Number of beds using ethanol treatment
Tidsram: 12 months
|
The primary endpoint of the study will be the effectiveness of ethanol for prevention of CLABSI compared to routine care.
This will be assessed at the end of the study (12 months)by comparing the number of beds being maintained by each regimine to determine if the distribution of line maintenance regimines is non-random in favor of either ethanol lock or saline maintenance.
|
12 months
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Ron Turner, MD, University of Virginia
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 15397
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Central Lines in ICU Patients
-
Centre Hospitalier Régional d'OrléansRekrytering
-
Wyeth is now a wholly owned subsidiary of PfizerAvslutad
-
University of California, San FranciscoAvslutad
-
Milton S. Hershey Medical CenterAvslutadCentral venkateter | Centrallinjen | PICC | Neuro ICU | Neurovetenskap ICU | CVCFörenta staterna
-
Assistance Publique - Hôpitaux de ParisAvslutadPatienter dog på intensivvårdsavdelning (ICU)Frankrike
-
Poitiers University HospitalAvslutadICU-patienter som kräver en central venös tillgångFrankrike
-
Indiana UniversityNational Heart, Lung, and Blood Institute (NHLBI); Children's Healthcare...AvslutadHyperglykemi | Pediatrisk patient (1m-21år) | ICU-intagningFörenta staterna
-
Hospices Civils de LyonAvslutadVuxen patient (över 18 år) inlagd på ICU för akut peritonitFrankrike
-
Minia UniversityHar inte rekryterat ännuEuthyroid Sick Syndromes in Traumatic Brain Injury Patient och GFAP-nivå
-
Brigham and Women's HospitalNortheastern UniversityAvslutadVenös tromboembolism | Patient Fall | Negativ droghändelse | Svår hypoglykemi | Sjukhusförvärvat trycksår | Central Line-Associated Bloodstream Infection (CLABSI) | Kateterrelaterad infektion | Opioidrelaterad allvarlig biverkning av läkemedel | Svårt sjukhus förvärvat Delerium | Snabb respons relaterad till...Förenta staterna
Kliniska prövningar på Normal Saline
-
Vanderbilt University Medical CenterAktiv, inte rekryterandePosturalt takykardisyndromFörenta staterna
-
Nicklaus Children's Hospital f/k/a Miami Children...AvslutadAfibrinogenemi | Hypofibrinogenemi | BlödningsstörningarFörenta staterna
-
St George's, University of LondonAvslutad
-
Qassim UniversityAvslutadApikal parodontit | Postoperativ smärta | TandmassanekroserSaudiarabien
-
Smigel, Liza, M.D.AvslutadRyggsmärta Nedre delen av ryggen KroniskFörenta staterna
-
Sorrento Therapeutics, Inc.AvslutadArtros, knä | Smärta, knäFörenta staterna
-
Shanghai Jiao Tong University School of MedicineWest China Hospital; Guangzhou General Hospital of Guangzhou Military Command och andra samarbetspartnersOkändHud; Deformitet, på grund av ärrKina
-
Ahmed SaadHawaa Fertility CenterHar inte rekryterat ännuFör tidig ovariesviktEgypten
-
Shanghai Jiao Tong University School of MedicineOkänd
-
Nihon UniversityIwate Medical University; Tokyo Medical and Dental University; Hiroshima... och andra samarbetspartnersAvslutad